ArticleHuman vaccines & immunotherapeutics2025
Durable response to third-line combination therapy in a metastatic colorectal cancer patient with BRAF V600E mutation: A case report.
Qun Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.